Contact Us
Amoxicillin Global Market Report 2025
Global Amoxicillin Market Report 2025
Item added to cart!

Published : December 2025

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF
Purchase This Report

Amoxicillin Global Market Report 2025

By Drug Class (Penicillin, Cephalosporin, Tetracycline, Macrolides, Sulfonamides), By Therapy Type (Monotherapy, Combinational Therapy), By Form (Tablets, Capsule, Suspensions, Syrup, Powder), By Infection Type (Skin Infections, Ear, Nose And Throat Infections, Stomach Infections, Lungs Infections, Urinary tract infections (UTI), Pneumonia, Bronchitis, Gonorrhea), By End User (Hospitals, Homecare, Specialty Clinics, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Amoxicillin Market Overview

• Amoxicillin market size has reached to $4.74 billion in 2024

• Expected to grow to $5.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.2%

• Growth Driver: Rising Infectious Disease Prevalence Fuels Growth In Amoxicillin Market

• Market Trend: Innovative Treatment Approaches In The Amoxicillin Market

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Amoxicillin Market?

Amoxicillin is a broad-spectrum antibiotic belonging to the penicillin group, used to treat various bacterial infections. It works by inhibiting the growth of bacteria by preventing them from forming cell walls, thereby effectively treating infections such as respiratory tract infections, urinary tract infections, skin infections, and certain types of bacterial endocarditis.

The main drug classes of amoxicillin are penicillin, cephalosporin, tetracycline, macrolides, and sulfonamides. Penicillin are a group of antibiotics that contain a core structure derived from the Penicillium mold. The various therapy types include monotherapy, and combinational therapy in various forms such as tablets, capsules, suspensions, syrup, and powder for various infection types such as skin infections, ear, nose, and throat infections, stomach infections, lung infections, urinary tract infections (UTI), pneumonia, bronchitis, gonorrhea. These are used by various end-users such as hospitals, homecare, specialty clinics, and others.

Amoxicillin Market Size and growth rate 2025 to 2029: Graph

What Is The Amoxicillin Market Size 2025 And Growth Rate?

The amoxicillin market size has grown steadily in recent years. It will grow from $4.74 billion in 2024 to $4.9 billion in 2025 at a compound annual growth rate (CAGR) of 3.4%. The growth in the historic period can be attributed to an increased understanding of antibiotics, a higher pace of research activities and developments, increased cases of cardiovascular diseases, increased demand for amoxicillin in the treatment of urinary tract infections, rise in the aging population.

What Is The Amoxicillin Market Growth Forecast?

The amoxicillin market size is expected to see steady growth in the next few years. It will grow to $5.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.2%. The growth in the forecast period can be attributed to growing impaired renal function, prevalence of lower respiratory infections, increasing skin infections, growing cases of lower respiratory tract infections, and rising prevalence of bacterial infections. Major trends in the forecast period include demand for generic amoxicillin, focus on combination therapies, interest in probiotics and immunotherapy, demand for antibiotics, and advanced healthcare facilities.

The forecast of 3.2% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of amoxicillin Active Pharmaceutical Ingredient(API) and finished dosage forms sourced from India and China, thereby reducing antibiotic accessibility and elevating primary care prescription expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Amoxicillin Market Segmented?

1) By Drug Class: Penicillin, Cephalosporin, Tetracycline, Macrolides, Sulfonamides

2) By Therapy Type: Monotherapy, Combinational Therapy

3) By Form: Tablets, Capsule, Suspensions, Syrup, Powder

4) By Infection Type: Skin Infections, Ear, Nose And Throat Infections, Stomach Infections, Lungs Infections, Urinary tract infections (UTI), Pneumonia, Bronchitis, Gonorrhea

5) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Penicillin: Penicillin G, Penicillin V, Extended-Spectrum Penicillins (Amoxicillin), Beta-Lactam Antibiotics

2) By Cephalosporin: First-Generation Cephalosporins (Cephalexin), Second-Generation Cephalosporins (Cefuroxime), Third-Generation Cephalosporins (Ceftriaxone), Fourth-Generation Cephalosporins (Cefepime)

3) By Tetracycline: Doxycycline, Minocycline, Tetracycline Hydrochloride

4) By Macrolides: Azithromycin, Erythromycin, Clarithromycin

5) By Sulfonamides: Sulfamethoxazole, Sulfadiazine, Sulfasalazine, Trimethoprim-Sulfamethoxazole Combination

What Is Driving The Amoxicillin Market? Rising Infectious Disease Prevalence Fuels Growth In Amoxicillin Market

The increasing prevalence of infectious diseases is expected to propel the growth of the amoxicillin market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites. Cases of infectious diseases are rising due to factors such as global travel, antimicrobial resistance, climate change affecting disease vectors, and population density. Amoxicillin helps treat infectious diseases by targeting bacterial cell wall synthesis, leading to bacterial cell death. Its broad-spectrum activity, rapid absorption, and ability to work synergistically with other antibiotics make IT a versatile and effective treatment for various bacterial infections. For instance, in January 2023, according to the National Institute of Health, a US-based public health research agency, urinary tract infections ranked seventh among the leading reasons for emergency department visits in the US, accounting for over 1 million visits annually. Of these, 22% (220,000) were classified as complicated UTIs, with approximately 100,000 cases resulting in hospital admissions each year. Therefore, the increasing prevalence of infectious diseases is driving the growth of the amoxicillin industry.

What Is Driving The Amoxicillin Market? Rising Healthcare Expenditure Drives Growth In Amoxicillin Market

The increase in healthcare expenditure is expected to propel the growth of the amoxicillin market going forward. Healthcare expenditure refers to the total amount of money spent on healthcare goods and services, including medical treatments, medications, hospitalizations, and preventive care, within a specified period, reflecting the overall cost of healthcare provision within a population. Healthcare expenditures are rising due to the increasing cost of advanced medical technologies, aging populations, and the prevalence of chronic diseases. Healthcare expenditures can benefit amoxicillin by ensuring wider accessibility and availability, which leads to higher prescription rates and improved patient outcomes. Enhanced funding also supports research and development, potentially leading to better formulations and broader usage of the antibiotic. For instance, in January 2024, according to the National Institutes of Health, a US-based government agency, healthcare expenditure in the US rose by 4.1% in 2022 to reach $4.5 trillion, representing a faster growth rate compared to the 3.2% increase observed in 2021. Therefore, the increase in healthcare expenditure is driving the growth of the amoxicillin industry.

Who Are The Major Players In The Global Amoxicillin Market?

Major companies operating in the amoxicillin market are Pfizer Inc., Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Merck KGaA, Teva Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Sun Pharmaceutical Industries Ltd., CSPC Pharmaceutical Group Limited, Torrent Pharmaceuticals GmbH, Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Intas Pharmaceuticals Ltd., Lupin Limited, Daewoong Pharmaceutical Co. Ltd., Centrient Pharmaceuticals, Wockhardt Limited, Ranbaxy Laboratories Ltd., Atman Pharmaceuticals, Sinopharm Weiqida Pharmaceutical Co. Ltd., Cipla Inc., Zydus Cadila

What Are The Key Trends Of The Global Amoxicillin Market? Innovative Treatment Approaches In The Amoxicillin Market

Major companies operating in the amoxicillin market are developing innovative drugs, such as reformulated versions of vonoprazan tablets, to enhance the treatment of Helicobacter pylori infections and improve patient outcomes. Vonoprazan is a novel potassium-competitive acid blocker (PCAB), which is a new class of acid suppressant medication that is reformulated. For instance, in May 2022, Phathom Pharmaceuticals, a US-based pharmaceutical company, received the U.S. Food and Drug Administration (FDA) approval of VOQUEZNA TRIPLE PAK (vonoprazan, amoxicillin, clarithromycin) and VOQUEZNA DUAL PAK (vonoprazan, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection in adults. These treatment regimens contain antibiotics conveniently packaged with vonoprazan, a novel potassium-competitive acid blocker (PCAB) and the first innovative acid suppressant from a new drug class approved in the U.S. in over 30 years.

Need data on a specific region in this market?

What Is The Regional Outlook For The Global Amoxicillin Market?

North America was the largest region in the amoxicillin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Amoxicillin Market?

The amoxicillin market consists of sales of oral formulations, liquid formulations, extended-release tablets, and specialty products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Amoxicillin Industry?

The amoxicillin market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the amoxicillin industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Amoxicillin Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $4.9 billion
Revenue Forecast In 2034 $5.56 billion
Growth Rate CAGR of 3.2% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Drug Class: Penicillin, Cephalosporin, Tetracycline, Macrolides, Sulfonamides
2) By Therapy Type: Monotherapy, Combinational Therapy
3) By Form: Tablets, Capsule, Suspensions, Syrup, Powder
4) By Infection Type: Skin Infections, Ear, Nose And Throat Infections, Stomach Infections, Lungs Infections, Urinary tract infections (UTI), Pneumonia, Bronchitis, Gonorrhea
5) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users Subsegments: 1) By Penicillin: Penicillin G, Penicillin V, Extended-Spectrum Penicillins (Amoxicillin), Beta-Lactam Antibiotics
2) By Cephalosporin: First-Generation Cephalosporins (Cephalexin), Second-Generation Cephalosporins (Cefuroxime), Third-Generation Cephalosporins (Ceftriaxone), Fourth-Generation Cephalosporins (Cefepime)
3) By Tetracycline: Doxycycline, Minocycline, Tetracycline Hydrochloride
4) By Macrolides: Azithromycin, Erythromycin, Clarithromycin
5) By Sulfonamides: Sulfamethoxazole, Sulfadiazine, Sulfasalazine, Trimethoprim-Sulfamethoxazole Combination
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Merck KGaA, Teva Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Sun Pharmaceutical Industries Ltd., CSPC Pharmaceutical Group Limited, Torrent Pharmaceuticals GmbH, Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Intas Pharmaceuticals Ltd., Lupin Limited, Daewoong Pharmaceutical Co. Ltd., Centrient Pharmaceuticals, Wockhardt Limited, Ranbaxy Laboratories Ltd., Atman Pharmaceuticals, Sinopharm Weiqida Pharmaceutical Co. Ltd., Cipla Inc., Zydus Cadila
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Amoxicillin Market Characteristics

3. Amoxicillin Market Trends And Strategies

4. Amoxicillin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Amoxicillin Growth Analysis And Strategic Analysis Framework

5.1. Global Amoxicillin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Amoxicillin Market Growth Rate Analysis

5.4. Global Amoxicillin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Amoxicillin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Amoxicillin Total Addressable Market (TAM)

6. Amoxicillin Market Segmentation

6.1. Global Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Penicillin

Cephalosporin

Tetracycline

Macrolides

Sulfonamides

6.2. Global Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monotherapy

Combinational Therapy

6.3. Global Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tablets

Capsule

Suspensions

Syrup

Powder

6.4. Global Amoxicillin Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Skin Infections

Ear, Nose And Throat Infections

Stomach Infections

Lungs Infections

Urinary tract infections (UTI)

Pneumonia

Bronchitis

Gonorrhea

6.5. Global Amoxicillin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Homecare

Specialty Clinics

Other End Users

6.6. Global Amoxicillin Market, Sub-Segmentation Of Penicillin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Penicillin G

Penicillin V

Extended-Spectrum Penicillins (Amoxicillin)

Beta-Lactam Antibiotics

6.7. Global Amoxicillin Market, Sub-Segmentation Of Cephalosporin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

First-Generation Cephalosporins (Cephalexin)

Second-Generation Cephalosporins (Cefuroxime)

Third-Generation Cephalosporins (Ceftriaxone)

Fourth-Generation Cephalosporins (Cefepime)

6.8. Global Amoxicillin Market, Sub-Segmentation Of Tetracycline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Doxycycline

Minocycline

Tetracycline Hydrochloride

6.9. Global Amoxicillin Market, Sub-Segmentation Of Macrolides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Azithromycin

Erythromycin

Clarithromycin

6.10. Global Amoxicillin Market, Sub-Segmentation Of Sulfonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Sulfamethoxazole

Sulfadiazine

Sulfasalazine

Trimethoprim-Sulfamethoxazole Combination

7. Amoxicillin Market Regional And Country Analysis

7.1. Global Amoxicillin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Amoxicillin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Amoxicillin Market

8.1. Asia-Pacific Amoxicillin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Amoxicillin Market

9.1. China Amoxicillin Market Overview

9.2. China Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Amoxicillin Market

10.1. India Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Amoxicillin Market

11.1. Japan Amoxicillin Market Overview

11.2. Japan Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Amoxicillin Market

12.1. Australia Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Amoxicillin Market

13.1. Indonesia Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Amoxicillin Market

14.1. South Korea Amoxicillin Market Overview

14.2. South Korea Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Amoxicillin Market

15.1. Western Europe Amoxicillin Market Overview

15.2. Western Europe Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Amoxicillin Market

16.1. UK Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Amoxicillin Market

17.1. Germany Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Amoxicillin Market

18.1. France Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Amoxicillin Market

19.1. Italy Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Amoxicillin Market

20.1. Spain Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Amoxicillin Market

21.1. Eastern Europe Amoxicillin Market Overview

21.2. Eastern Europe Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Amoxicillin Market

22.1. Russia Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Amoxicillin Market

23.1. North America Amoxicillin Market Overview

23.2. North America Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Amoxicillin Market

24.1. USA Amoxicillin Market Overview

24.2. USA Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Amoxicillin Market

25.1. Canada Amoxicillin Market Overview

25.2. Canada Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Amoxicillin Market

26.1. South America Amoxicillin Market Overview

26.2. South America Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Amoxicillin Market

27.1. Brazil Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Amoxicillin Market

28.1. Middle East Amoxicillin Market Overview

28.2. Middle East Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Amoxicillin Market

29.1. Africa Amoxicillin Market Overview

29.2. Africa Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Amoxicillin Market Competitive Landscape And Company Profiles

30.1. Amoxicillin Market Competitive Landscape

30.2. Amoxicillin Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis

31. Amoxicillin Market Other Major And Innovative Companies

31.1. Merck KGaA

31.2. Teva Pharmaceutical Industries Ltd.

31.3. Alkem Laboratories Ltd.

31.4. Sun Pharmaceutical Industries Ltd.

31.5. CSPC Pharmaceutical Group Limited

31.6. Torrent Pharmaceuticals GmbH

31.7. Aurobindo Pharma Limited

31.8. Hikma Pharmaceuticals PLC

31.9. Intas Pharmaceuticals Ltd.

31.10. Lupin Limited

31.11. Daewoong Pharmaceutical Co. Ltd.

31.12. Centrient Pharmaceuticals

31.13. Wockhardt Limited

31.14. Ranbaxy Laboratories Ltd.

31.15. Atman Pharmaceuticals

32. Global Amoxicillin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Amoxicillin Market

34. Recent Developments In The Amoxicillin Market

35. Amoxicillin Market High Potential Countries, Segments and Strategies

35.1 Amoxicillin Market In 2029 - Countries Offering Most New Opportunities

35.2 Amoxicillin Market In 2029 - Segments Offering Most New Opportunities

35.3 Amoxicillin Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Amoxicillin Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Amoxicillin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Amoxicillin Market, Sub-Segmentation Of Penicillin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Amoxicillin Market, Sub-Segmentation Of Cephalosporin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Amoxicillin Market, Sub-Segmentation Of Tetracycline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Amoxicillin Market, Sub-Segmentation Of Macrolides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Amoxicillin Market, Sub-Segmentation Of Sulfonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Amoxicillin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Amoxicillin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Pfizer Inc. Financial Performance
  • Table 82: Sanofi S.A. Financial Performance
  • Table 83: AstraZeneca Plc Financial Performance
  • Table 84: Novartis AG Financial Performance
  • Table 85: GlaxoSmithKline Plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Amoxicillin Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Amoxicillin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Amoxicillin Market, Sub-Segmentation Of Penicillin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Amoxicillin Market, Sub-Segmentation Of Cephalosporin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Amoxicillin Market, Sub-Segmentation Of Tetracycline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Amoxicillin Market, Sub-Segmentation Of Macrolides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Amoxicillin Market, Sub-Segmentation Of Sulfonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Amoxicillin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Amoxicillin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Pfizer Inc. Financial Performance
  • Figure 82: Sanofi S.A. Financial Performance
  • Figure 83: AstraZeneca Plc Financial Performance
  • Figure 84: Novartis AG Financial Performance
  • Figure 85: GlaxoSmithKline Plc Financial Performance

Frequently Asked Questions

Amoxicillin is a broad-spectrum antibiotic belonging to the penicillin group, used to treat various bacterial infections. It works by inhibiting the growth of bacteria by preventing them from forming cell walls, thereby effectively treating infections such as respiratory tract infections, urinary tract infections, skin infections, and certain types of bacterial endocarditis. For further insights on this market, request a sample here

The market major growth driver - Rising Infectious Disease Prevalence Fuels Growth In Amoxicillin Market. For further insights on this market, request a sample here

The amoxicillin market size has grown steadily in recent years. It will grow from $4.74 billion in 2024 to $4.9 billion in 2025 at a compound annual growth rate (CAGR) of 3.4%. The growth in the historic period can be attributed to an increased understanding of antibiotics, a higher pace of research activities and developments, increased cases of cardiovascular diseases, increased demand for amoxicillin in the treatment of urinary tract infections, rise in the aging population. The amoxicillin market size is expected to see steady growth in the next few years. It will grow to " $5.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.2%. The growth in the forecast period can be attributed to growing impaired renal function, prevalence of lower respiratory infections, increasing skin infections, growing cases of lower respiratory tract infections, and rising prevalence of bacterial infections. Major trends in the forecast period include demand for generic amoxicillin, focus on combination therapies, interest in probiotics and immunotherapy, demand for antibiotics, and advanced healthcare facilities. For further insights on this market, request a sample here

The amoxicillinmarket covered in this report is segmented –
1) By Drug Class: Penicillin; Cephalosporin; Tetracycline; Macrolides; Sulfonamides
2) By Therapy Type: Monotherapy; Combinational Therapy
3) By Form: Tablets; Capsule; Suspensions; Syrup; Powder
4) By Infection Type: Skin Infections; Ear, Nose And Throat Infections; Stomach Infections; Lungs Infections; Urinary tract infections (UTI); Pneumonia; Bronchitis; Gonorrhea
5) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users Subsegments:
1) By Penicillin: Penicillin G; Penicillin V; Extended-Spectrum Penicillins (Amoxicillin); Beta-Lactam Antibiotics
2) By Cephalosporin: First-Generation Cephalosporins (Cephalexin); Second-Generation Cephalosporins (Cefuroxime); Third-Generation Cephalosporins (Ceftriaxone); Fourth-Generation Cephalosporins (Cefepime)
3) By Tetracycline: Doxycycline; Minocycline; Tetracycline Hydrochloride
4) By Macrolides: Azithromycin; Erythromycin; Clarithromycin
5) By Sulfonamides: Sulfamethoxazole; Sulfadiazine; Sulfasalazine; Trimethoprim-Sulfamethoxazole Combination For further insights on this market,
request a sample here

North America was the largest region in the amoxicillin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amoxicillin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the amoxicillin market are Pfizer Inc., Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Merck KGaA, Teva Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Sun Pharmaceutical Industries Ltd., CSPC Pharmaceutical Group Limited, Torrent Pharmaceuticals GmbH, Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Intas Pharmaceuticals Ltd., Lupin Limited, Daewoong Pharmaceutical Co. Ltd., Centrient Pharmaceuticals, Wockhardt Limited, Ranbaxy Laboratories Ltd., Atman Pharmaceuticals, Sinopharm Weiqida Pharmaceutical Co. Ltd., Cipla Inc., Zydus Cadila. For further insights on this market, request a sample here.

Major trends in this market include Innovative Treatment Approaches In The Amoxicillin Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon